ChiCTR2100048111 版本V1.0 版本创建时间2021/07/02 00:26:33 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100048111 

最近更新日期:

Date of Last Refreshed on:

2021-07-02 00:24:45 

注册时间:

Date of Registration:

2021-07-02 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

通过研究阑尾炎的聚集性证明一种新型非穿孔性阑尾炎

Public title:

Demonstration of a new entity of non-perforated appendicitis through studying cluster of appendicitis

注册题目简写:

阑尾炎和聚集性

English Acronym:

appendicitis and cluster

研究课题的正式科学名称:

阑尾炎的诊断和流行病学

Scientific title:

Diagnosis and epidemiology of appendicitis

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

郭毅 

研究负责人:

郭毅 

Applicant:

Guo Yi 

Study leader:

Guo Yi 

申请注册联系人电话:

Applicant telephone:

+86 027-18827018282

研究负责人电话:

Study leader's
telephone:

+86 027-18827018282

申请注册联系人传真 :

Applicant Fax:

+86 027-68758648

研究负责人传真:

Study leader's fax:

+86 027-68758648

申请注册联系人电子邮件:

Applicant E-mail:

guoyi@whu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

guoyi@whu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖北武汉武昌东湖路115号

研究负责人通讯地址:

湖北武汉武昌东湖路115号

Applicant address:

115 Donghu Road, Wuchang, Wuhan 430071, Hubei Province, China

Study leader's address:

115 Donghu Road, Wuchang, Wuhan 430071, Hubei Province, China

申请注册联系人邮政编码:

Applicant postcode:

430071

研究负责人邮政编码:

Study leader's postcode:

430071

申请人所在单位:

武汉大学健康学院

Applicant's institution:

Wuhan university School of Health Medicine

研究负责人所在单位:

武汉大学健康学院

Affiliation of the Leader:

Wuhan university School of Health Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2021YF0051

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

武汉大学医学院医学伦理委员会

Name of the ethic committee:

Ethic board at Wuhan University School of Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2021-05-27 00:00:00

伦理委员会联系人:

刘珂

Contact Name of the ethic committee:

Liu,Ke

伦理委员会联系地址:

湖北武汉武昌东湖路115号

Contact Address of the ethic committee:

115 Donghu Road, Wuchang, Wuhan 430071, Hubei Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

18071508395

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

武汉大学健康学院

Primary sponsor:

Wuhan University School of Health Science

研究实施负责(组长)单位地址:

湖北武汉武昌东湖路115号

Primary sponsor's address:

115 Donghu Road, Wuchang, Wuhan 430071, Hubei Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖北

市(区县):

Country:

China

Province:

Hubei

City:

单位(医院):

武汉大学医学院

具体地址:

湖北武汉武昌东湖路115号

Institution
hospital:

Wuhan Univversity School of Medcine

Address:

115 Donghu Road, Wuchang, Wuhan

经费或物资来源:

无专门经费

Source(s) of funding:

no funding

研究疾病:

阑尾炎  

Target disease:

appendicitis

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

本研究旨在通过对阑尾炎聚集性的研究,证明“急性出血性阑尾炎”是一种新型的非穿孔性阑尾炎,在不同省份发生,具有传染病的流行病学特征。第二个目的是确定阑尾炎聚集性发生的环境,并为发现新的阑尾炎聚集性和证明新的阑尾炎实体提供建议。  

Objectives of Study:

The aim of this study was to demonstrate through studying cluster of appendicitis that “acute hemorrhagic appendicitis” was a new entity of non-perforated appendicitis occurring reproducibly in different provinces, with features of infectious diseases in epidemiology. A second aim was to confirm common settings of cluster of appendicitis and to provide suggestion to find new cluster of appendicitis and demonstrate new entity of appendicitis.

药物成份或治疗方案详述:

这是一项关于阑尾炎聚集性的流行病学研究和临床病例分析,不属于治疗研究。因此,有关干预措施部分我们不能填写具体内容,用填“n/a”代替。本研究绝大部分是回顾性的,仅健康教育是前瞻性的,所以我们填写注册号状态:回顾性研究。 根据美国德克萨斯州、中国武汉等地阑尾炎聚集性发生的情况,我们认为集体生活单位可能是阑尾炎聚集性的多发地方,因此我们关注学校和军营。我们对阑尾炎聚集性进行现场调查,并对流行病学、临床、实验室和病理资料进行分析。 按照Reingold AL的[25]方法对阑尾炎的聚集性进行流行病学调查。 流行病学、临床和病理研究 在流行病学调查中,我们将按人群、时间、地点收集阑尾炎发病率、人群、环境、发病时间和持续时间、暴露史、生活习惯、环境卫生以及我们采取的预防措施等资料。 临床研究采用标准化数据采集表收集患者临床、实验室检查信息,包括临床表现、体格检查、体温、白细胞计数、中性粒细胞百分比。 病理检查,穿孔性阑尾炎或阑尾脓肿合并为单一的类别称为“穿孔性阑尾炎”。非穿孔性阑尾炎定义为除穿孔性阑尾炎或阑尾脓肿外的任何阑尾炎。 我们将仔细检查阑尾炎群集的病理特征。如前所述,由于聚集性往往由共同的原因导致,因此聚集性病例中几乎每一位患者都属于同一阑尾炎实体,并出现在同一疾病的某一阶段。结合每个患者的病理特征,我们可以了解阑尾炎聚集病例的全部自然史。这样我们就可以证明穿孔性阑尾炎和非穿孔性阑尾炎是否为不同的实体或同一实体阑尾炎的不同阶段。 本研究经武汉大学医学院医学伦理委员会批准,并获得每个受访者的书面知情同意。 纳入本研究需要符合以下纳入标准:急性阑尾炎的典型临床表现和急性阑尾炎的组织学特征。 

Description for medicine or protocol of treatment in detail:

According to the setting of cluster of appendicitis in Texas, USA and Wuhan, China, we assumed that collective living units might be places where cluster of appendicitis occurs frequently, so we paid attention to school. military camp. We studied the cluster of appendicitis by means of field investigation and analyze epidemiologic, clinical, laboratory and pathologic data. Epidemiological investigation of cluster was carried out according to Reingold AL’s methods[25]. Epidemiological, Clinical and Pathological Investigation For epidemiological investigation, we will collect data of distribution by person, time and place, including incidence rate of appendicitis, population, setting, start time and duration, exposure history, living habits, environmental sanitation, and preventive measure we take. For clinical investigation, the patients’ clinical, laboratory examination information were collected on a standardized data collection form, including clinical manifestation, physical examination, body temperature, white blood cell count and percentage of neutrophile. For pathological investigation, perforated appendicitis or appendiceal abscess were aggregated into a single category called “perforated appendicitis”. Nonperforated appendicitis was defined as having any appendicitis except for perforated appendicitis or appendiceal abscess[6]. We will examinate pathological feature of appendicitis in cluster carefully. As stated before, because cluster often results from common cause, therefore almost every patient in cluster belongs to the same entity of appendicitis and appeared in certain stage of same entity. Connecting each patient’s pathological feature, we can know full natural histories of appendicitis in cluster. In this way, we can demonstrate whether or not perforated appendicitis and non-perforated appendicitis are different entities or different stage of same entity of appendicitis. The study was approved by ethic board at collaborating hospital and Wuhan University School of Medicine, written informed consent will be obtained from each respondents. To be included in this study, the following inclusion criteria have to be met: typical clinical manifestations of acute appendicitis and histologic features of acute appendicitis.  

纳入标准:

纳入本研究需要符合以下纳入标准:急性阑尾炎的典型临床表现和急性阑尾炎的组织学特征。 所有阑尾切除术的病理切片均在武汉大学中南医院病理科复查。

Inclusion criteria

To be included in this study, the following inclusion criteria have to be met: typical clinical manifestations of acute appendicitis and histologic features of acute appendicitis. All histologic slides from appendectomy were re-examined in Department of Pathology, Zhongnan Hospital of Wuhan University.

排除标准:

病历记录不全和到非合作医院治疗的病人予以排除。

Exclusion criteria:

Patients with incomplete medical records and treatment at non-cooperative hospitals were excluded.

研究实施时间:

Study execute time:

From 2005-08-01 00:00:00 To 2018-07-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2005-08-01 00:00:00 To 2018-07-01 00:00:00

干预措施:

Interventions:

组别:

Case series

样本量:

973

Group:

Case series

Sample size:

干预措施:

n/a

干预措施代码:

Intervention:

n/a

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江西省 

市(区县):

 

Country:

China

Province:

Jiangxi

City:

单位(医院):

南昌市十七中学 

单位级别:

中学 

Institution
hospital:

Nanchang No 17 high school

Level of the institution:

high school

测量指标:

Outcomes:

指标中文名:

发病率

指标类型:

主要指标

Outcome:

incidence rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

病理检查

指标类型:

主要指标

Outcome:

pathological examination

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体温

指标类型:

次要指标

Outcome:

body temperature

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

白细胞计数

指标类型:

次要指标

Outcome:

white blood cell count

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

阑尾

组织:

Sample Name:

appendix

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 12 years
最大 Max age 17 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

这是一项有关阑尾炎聚集性的研究,不是治疗性研究,不需随机化。n/a

Randomization Procedure (please state who generates the random number sequence and by what method):

We conducted a study of cluster of appendicitis, not a therapeutic study, so no randomization is needed. n/a

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

这是一项有关阑尾炎聚集性的研究,不是治疗性研究,不需盲法。n/a

Blinding:

n/a. for the same reason as above box.

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

原始数据将随稿件一起作为附件上传到医学期刊社,由期刊社决定如何公布。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The data will be uploaded with the manuscript in its original form as an attachment to the medical journal, which decides how to share it.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

有关临床数据已在2005年至2010间完成,我们采用的是病例记录表。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data were collected between 2005 and 2010, using case record form.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2021-07-02 00:24:45